Background Miscarriage, defined as the spontaneous loss of a pregnancy before 24 weeks'
gestation, is common with approximately 25% of women experiencing a miscarriage in their …

Background Approximately 12% of pregnancies end in an early miscarriage (up to week 12+
0 of pregnancy). Over the past 10 to 15 years, two alternatives to curettage have appeared in …

Background Spontaneous abortion is one of the prevalent adverse reproductive outcomes,
which seriously threatens maternal health around the world. Objective The current study is …

STUDY QUESTION Can maternal serum levels of soluble programmed cell death-1 (sPD-1)
and its ligand (sPD-L1) serve as biomarkers for missed miscarriage (MM)? SUMMARY …

Background Misoprostol is a synthetic analogue of prostaglandin E1 (PGE1) with gastric
secretion inhibitory and mucosal protection properties through the production of bicarbonate …

Abstract Objective Oxidative stress biomarkers (OSBs) may be strongly associated with
disease progression and recurrent pregnancy loss (RPL). However, the research on …

STUDY QUESTION What are clinical predictors for successful medical treatment in case of
early pregnancy loss (EPL)? SUMMARY ANSWER Use of mifepristone, BMI, number of …

Combination of Mifepristone and Misoprostol for First-Trimes... : Obstetrical & Gynecological Survey
Combination of Mifepristone and Misoprostol for First-Trimester Medical Abortion: A …

Background This study focuses on the risk of early miscarriage in patients undergoing in
vitro fertilization (IVF) or intracytoplasmic sperm injection (ICSI). These patients commonly …

Objective To study the rate of surgical intervention for unsuccessful medical treatment in
early pregnancy loss (EPL), according to gestational size by ultrasound (GS‐US). Methods …